[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"St.Gallen University of Applied Sciences\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":73},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":29,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100592913",false,"NCT06999616","Physical Activity in Cancer Patients in an Oncology Day Clinic - Implementing a Person-centered Program Led by Nurses","Promoting Physical Activity in Individuals With Cancer in an Oncology Day Clinic - Testing the Feasibility of the Implementation of a Physical Activity Concept Within an Interprofessional Team Led by Nurses OnkoMoveNurse - Proof of Concept","OnkoMoveNurse","Inclusion Criteria:\n\n1. diagnosis of cancer,\n2. at least three treatments at the oncology outpatient clinic in Münsterlingen during the study period,\n3. aged ≥18 years, and\n4. sufficient knowledge of German.\n\nExclusion Criteria:\n\n* pregnancy","ALL","18 Years",{"count":19,"type":20},50,"ESTIMATED","OBSERVATIONAL","Background: Physical activity has demonstrated benefits in alleviating side effects and improving well-being in people with cancer. However, activity levels remain low during systemic treatment. Nurses are optimally positioned to lead interventions fostering an activity-friendly culture.\n\nObjective: This study aims to evaluate the feasibility and potential effects of the nurse-led, interprofessionally developed physical activity concept OncoMoveNurse in an outpatient oncology setting.\n\nMethods: Using a mixed-methods design over 15 months (10\u002F2024-12\u002F2025), the study includes implementation and evaluation phases. Quantitative data (n=50 patients, collected from 06\u002F2025-09\u002F2025) will assess primary (physical activity behavior) and secondary outcomes (self-efficacy, well-being, mood) via validated PROMs. Qualitative insights will be gathered through digital storytelling (n=2 patients, n=2 nurses) and one focus group (n=8 interprofessional team members). Inclusion criteria for patients include age ≥18, cancer diagnosis, at least three treatments in the day clinic, and sufficient German language skills.\n\nIntervention: OncoMoveNurse comprises five adaptable components: modular activity structure, safety framework, communication strategy, a team approach, and person-centered orientation. Supporting materials (e.g., posters, videos, exercise tools) and tailored implementation strategies were co-developed in alignment with core values.\n\nAnalysis: Quantitative data will be analyzed using SPSS (paired t-tests, p\\\u003C.05); qualitative data via content analysis in MAXQDA. A mixed-methods synthesis will integrate findings.\n\nEthics \\& Data Protection: Patient data collection will commence following ethics approval. All data are anonymized, stored securely, and handled in accordance with Swiss data protection laws.\n\nConclusion: This study will provide insights into the feasibility of nurse-led physical activity promotion in outpatient oncology and inform future outcome evaluations.",[24,25,26,27,28],"Neoplasms","Motor Activity","Chemotherapy","Antitumor Drugs","Activity Level",[30,31,32,33,34,35,36],"activity promotions","proof-of-concept","implementation","activity concept","excercise","cancer patient","physical activity","RECRUITING","2025-12-03",{"date":40,"type":41},"2025-12-10","ACTUAL",{"date":43,"type":41},"2025-08-01",{"date":45,"type":20},"2026-08-31",{"name":47,"class":48},"St.Gallen University of Applied Sciences","OTHER",1,{"id":51,"slug":4,"hasResults":10,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":49},"100551780","NCT06464536","Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy","Tight Surgical Gloves to Prevent Chemotherapy-induced Peripheral Neuropathy: A Randomized Controlled Trial to Evaluate the Efficacy of Compression Therapy in Patients With Taxane-based Chemotherapy for Breast and Urogenital Cancer","ComPrendo","Inclusion Criteria:\n\n* Mamma or Urogenital carcinoma\n* first treatment with Taxanes (nab-Paclitaxel, Paclitaxel, Docetaxel)\n* signed informed consent\n* sufficient proficiency in German or English\n\nExclusion Criteria:\n\n* other therapy that could have caused peripheral neuropathy within the last 24 months (Taxane, Platin, Vincaalkaloids, etc.)\n* History of neuropathy such as Raynaud's phenomenon, fibromyalgia and diabetic polyneuropathy\n* Use of polyneuropathy medications including duloxetine; gabapentin\u002Fpregabalin; topical amitriptyline, ketamine, baclofen; oral cannabinoids; tricyclic antidepressants; and ganglioside monosialic acid\n* such impaired cognition that prevents participation in the study according to the assessment of the caregivers",{"count":58,"type":20},114,"INTERVENTIONAL",[61],"NA","In this study, the effect of compression therapy of the hands with tight surgical gloves to reduce peripheral neuropathy in adult patients during the application of taxanes will be evaluated.",[64],"Taxane-induced Peripheral Neuropathy","2025-05-13",{"date":67,"type":41},"2025-05-16",{"date":69,"type":41},"2025-02-03",{"date":71,"type":20},"2026-03",{"name":47,"class":48},""]